ANG Lifesciences India Limited (BOM:540694)

ANG Lifesciences India Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	36.36	3.19	3.24	3.46	38.63
Short-Term Investments	-	54.17	58.53	63.06	-
Cash & Short-Term Investments	36.36	57.35	61.78	66.52	38.63
Cash Growth	-36.61%	-7.16%	-7.14%	72.20%	7.29%
Accounts Receivable	665.39	732.78	831.48	1,021	587.43
Other Receivables	-	8.08	15.19	10.82	54.71
Receivables	665.39	740.85	846.67	1,031	642.15
Inventory	541.09	477.66	484.87	369.59	192.59
Prepaid Expenses	-	2.09	3.43	3.04	1
Other Current Assets	410.56	511.41	451.78	457.61	284.33
Total Current Assets	1,653	1,789	1,849	1,928	1,159
Property, Plant & Equipment	571.93	583.97	881.48	926.14	238.65
Long-Term Investments	0.26	0.26	0.26	0.26	35.2
Other Intangible Assets	-	-	-	-	2.31
Long-Term Deferred Tax Assets	63.72	44.59	41.2	42.85	-
Other Long-Term Assets	6.64	6.19	5.16	12.93	1.66
Total Assets	2,296	2,424	2,777	2,910	1,437
Accounts Payable	660.74	661.79	681.86	706.29	400.4
Accrued Expenses	2.03	98.47	62.56	59.61	77.84
Short-Term Debt	-	503.25	449.29	465.84	329.39
Current Portion of Long-Term Debt	615.72	49.7	45.16	87.74	31.93
Current Portion of Leases	9.04	8.18	5.04	-	-
Current Income Taxes Payable	0.76	42.63	176.63	189.11	50.47
Other Current Liabilities	146.08	81.64	202.31	154.3	25.59
Total Current Liabilities	1,434	1,446	1,623	1,663	915.61
Long-Term Debt	188.61	139.49	184.94	216.37	70.29
Long-Term Leases	18.7	27.73	23.06	-	-
Long-Term Deferred Tax Liabilities	-	13.34	14.91	6.15	2.39
Other Long-Term Liabilities	1.75	23.94	58.08	172.25	27.86
Total Liabilities	1,656	1,662	1,914	2,073	1,021
Common Stock	130.58	130.58	130.58	103.67	51.83
Additional Paid-In Capital	-	56.17	56.17	63.09	105.06
Retained Earnings	-	529.11	628.51	624.02	258.94
Comprehensive Income & Other	509.18	46.91	46.91	46.91	-
Shareholders' Equity	639.76	762.77	862.18	837.69	415.83
Total Liabilities & Equity	2,296	2,424	2,777	2,910	1,437
Total Debt	832.06	728.37	707.48	769.95	431.61
Net Cash (Debt)	-795.7	-671.01	-645.71	-703.43	-392.98
Net Cash Per Share	-60.38	-51.39	-49.70	-54.28	-30.33
Filing Date Shares Outstanding	13.21	13.06	13.06	12.96	12.96
Total Common Shares Outstanding	13.21	13.06	13.06	12.96	12.96
Working Capital	219.03	343.7	225.69	265.23	243.08
Book Value Per Share	48.44	58.41	66.03	64.65	32.09
Tangible Book Value	639.76	762.77	862.18	837.69	413.52
Tangible Book Value Per Share	48.44	58.41	66.03	64.65	31.91
Land	-	57.78	148.57	153.43	23.81
Buildings	-	409.6	515.7	519.71	130.83
Machinery	-	693.16	774.45	746.59	218.87
Construction In Progress	-	-	-	-	4.01

Source: S&P Global Market Intelligence. Standard template. Financial Sources.